MediView XR, Inc., is an Ohio-based medical device startup that has exclusively licensed patented intellectual property and know-how from the Cleveland Clinic Foundation. MediView is refining and further developing that IP to create a revolutionary Extended Reality Surgical Navigation System with initial intended use in the biopsy and ablation of cancerous tumors. MediView has contracted with Lerner Research Biomedical Engineering at the Cleveland Clinic as a continuing development partner. Through distinct disruptive technology this team is poised to redefine percutaneous oncology procedures with Extended Reality Navigation.
MediView’s RTFHV (Real Time Fused Holographic Visualization) technology has emerged as the market-disruptor in Surgical Extended Reality Navigation. The startup venture is engineered for rapid acceleration into commercialization. MediView’s RTFHV Extended Reality procedural guidance will provide distinct clinical capabilities with value propositions for all vested parties, including: healthcare c-suite with peer reviewed cost efficiency, surgeons rendering care, and most importantly the patient’s battle with various disease states.